Karmen Wong

HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta‐analysis)

D. Jackson, Karmen Wong, Wing Kit Lai, 2022, Vox sanguinis.

Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia

E. Lim, S. C. Lee, Sing-Huang Tan, 2022, Therapeutic advances in medical oncology.

Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody–drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore

S. Choo, W. Yong, L. Teo, 2022, Expert opinion on drug metabolism & toxicology.

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma

V. Lee, R. Poon, D. Kwong, 2015, OncoTargets and therapy.